Clinical trial
Phase II Study of NPO-13 in Patients Undergoing Colonoscopy
NCT04097574 is registered in ClinicalTrials.gov with Nihon Pharmaceutical Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of NPO-13 in Patients Undergoing Colonoscopy
- Lead sponsor
- Nihon Pharmaceutical Co., Ltd
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 26, 2019
- Completion date
- March 26, 2020
- Enrollment
- 158 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
bowel disease